Advanced prostate cancer is associated with a decreased activity of butyrycholinesterase (BCHE) [62] and BCHE is downregulated in androgen-independent prostate cancer C4-2 cells as compared to androgen-dependent LNCaP cells [63]. This evidence concerns the gene BCHE and prostate carcinoma.